Related references
Note: Only part of the references are listed.On the origins of drug polypharmacology
Xavier Jalencas et al.
MEDCHEMCOMM (2013)
Can we discover pharmacological promiscuity early in the drug discovery process?
Jens-Uwe Peters et al.
DRUG DISCOVERY TODAY (2012)
Comparing Measures of Promiscuity and Exploring Their Relationship to Toxicity
Xiangyun Wang et al.
MOLECULAR INFORMATICS (2012)
Molecular complexity and fragment-based drug discovery: ten years on
Andrew R. Leach et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Predicting in vivo safety characteristics using physiochemical properties and in vitro assays
Nigel Greene et al.
FUTURE MEDICINAL CHEMISTRY (2011)
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
W. Patrick Walters et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Stephen D. Roughley et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Getting pharmaceutical R&D back on target
Mark E. Bunnage
NATURE CHEMICAL BIOLOGY (2011)
Factors Determining the Selection of Organic Reactions by Medicinal Chemists and the Use of These Reactions in Arrays (Small Focused Libraries)
Tony W. J. Cooper et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Enthalpic Efficiency of Ligand Binding
Gyoergy G. Ferenczy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
Jens-Uwe Peters et al.
CHEMMEDCHEM (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Generation of a set of simple, interpretable ADMET rules of thumb
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models
M. Paul Gleeson et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates
Jeffrey A. Kramer et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Modeling promiscuity based on in vitro safety pharmacology profiling data
Kamal Azzaoui et al.
CHEMMEDCHEM (2007)
Predicting in vivo drug interactions from in vitro drug discovery data
LC Wienkers et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
A bioavailability score
YC Martin
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Prospects for productivity
B Booth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Molecular complexity and its impact on the probability of finding leads for drug discovery
MM Hann et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
Share Paper
